Skip to main content

Table 2 Demographic data, indication for cfLVAD-implantation and medical history of patients included in the derivation and the validation cohort. Values are expressed as numbers and % of patients, mean ± SD, or median [Interquartile Range]

From: Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors

  Derivation cohort
118 patients
Validation cohort
72 patients
Demographic data
 Age (years) 49.4 ± 12.8 51.2 ± 13.0
 Male gender 83 (70.3%) 49 (68.1%)
 Weight (kg) 75.0 ± 14.0 75.6 ± 15.0
 Height (cm) 177 ± 9 174 ± 23
 BSA (m2) 1.92 ± 0.19 1.92 ± 0.22
 BMI (kg·m−2) 23.9 ± 4.1 24.1 ± 3.8
Indication LVAD implantation
 Hypertrophic CMP 3 (2.5%) 1 (1.4%)
 Ischemic CMP 25 (21.2%) 16 (22.2%)
 Non-compaction CMP 5 (4.2%) 0 (0.0%)
 Dilating CMP 85 (72.0%) 52 (72.2%)
 Myocarditis 0 (0.0%) 1 (1.4%)
 Congenital CMP 0 (0.0%) 1 (1.4%)
 Toxic CMP 0 (0.0%) 1 (1.4%)
Medical History
 Diabetes Mellitus 9 (7.6%) 10 (13.9%)
 Hypertension 10 (8.5%) 10 (13.9%)
 Hypercholesterolemia 12 (10.2%) 11 (15.3%)
 Smoking history 64 (54.2%) 25 (34.7%)
 Thyroid disease 15 (12.7%) 7 (9.7%)
 COPD 13 (11.0%) 9 (12.5%)
 Stroke 7 (5.9%) 4 (5.6%)
 Transient Ischemic Attack 6 (5.1%) 3 (4.2%)
 Previous Cardiothoracic surgery 14 (11.9%) 13 (18.1%)
 HMIIRS 2.4 ± 1.3 1.5 ± 1.0
 Euroscore II 22.1 [17.3–34.0] 19.0 [12.3–34.7]
Intermacs Class
 Intermacs class I 15 (12.7%) 1 (1.4%)
 Intermacs class II 63 (53.4%) 31 (43.1%)
 Intermacs class III 33 (28.0%) 27 (37.5%)
 Intermacs class IV 7 (5.9%) 12 (16.7%)
 Intermacs class V 0 (0.0%) 0 (0.0%)
 Intermacs class VI 0 (0.0%) 1 (1.4%)